Controlled cell killing by a recombinant nonsegmented negative-strand RNA virus

Virology

Volumn 293, Issue 1, 2002, Pages 192-203

  Parks, Griffith D ^a   Young, Virginia A ^a   Koumenis, Constantinos ^a   Wansley, Elizabeth K ^a   Layer, Jennifer L ^a   Cooke, Kelly M ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; PRODRUG; THYMIDINE KINASE; VIRUS ENZYME; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL KILLING; CELL STRUCTURE; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; GENE CONSTRUCT; GENETIC CODE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; KIDNEY CELL; MICROSCOPY; MOUSE; NONHUMAN; PARAMYXOVIRUS SIMIAN VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA VIRUS; TIME; TITRIMETRY; TUMOR CELL DESTRUCTION; VIDEORECORDING; VIRUS GENE; VIRUS INFECTION; VIRUS RECOMBINANT;

PARAMYXOVIRIDAE; RNA VIRUSES; SIMIAE; SIMIAN PARAINFLUENZA VIRUS 5; SIMPLEXVIRUS;

EID: 0036343248     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1298     Document Type: Article

References (42)

1. Human gene therapy
2. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect"
3. Multiplication of a myxovirus (SV5) with minimal cytopathic effects and without interference
4. Nonsegmented negative-strand RNA viruses: Genetics and manipulation of viral genomes
5. The V protein of simian virus 5 inhibits interferon signaling by targeting STAT1 for proteasome-mediated degradation
6. Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?
7. Differential ganciclovir-mediated cell killing by glutamine 125 mutants of herpes simplex virus type 1 thymidine kinase
8. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine
9. p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection
10. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
11. Regulators of apoptosis on the road to persistent alphavirus infection
12. Irreversible G2-M arrest and cytoskeletal reorganization induced by cytotoxic nucleoside analogues
13. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells
14. Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen
15. The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells
16. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene
17. Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: Roles of conserved residues in cell fusion
18. Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene
19. Regulation of p53 by hypoxia: Dissociation of transcriptional repression and apoptosis from p53-dependent transactivation
20. Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro
21. Paramyxovirus fusion: A hypothesis for changes
22. Paramyxoviridae: The viruses and their replication
23. The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein
24. The paramyxovirus simian virus 5 V protein slows progression of the cell cycle
25. Herpes simplex virus thymidine kinase-green fluorescent protein fusion gene: New tool for gene transfer studies and gene therapy
26. Differential efficacy of suicide gene therapy by herpes simplex virus-thymidine kinase gene reflects the status of p53 gene in human esophageal cancer cells
27. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: Role of gap-junctional intercellular communication
28. Drug sensitivity ("suicide") genes for selective cancer therapy
29. Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5
30. Genetic engineering of infectious negative-strand RNA viruses
31. Increased readthrough transcription across the simian virus 5 M-F gene junction leads to growth defects and a global inhibition of viral mRNA synthesis
32. Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide
33. Reverse genetics of negative-strand RNA viruses: Closing the circle
34. Paramyxovirus persistence, consequences for host and virus
35. The highly diverse intergenic regions of the paramyxovirus SV5 cooperate with the gene end U tract in viral transcription termination and can influence reinitiation at a downstream gene
36. Viruses and apoptosis
37. Accommodation of foreign genes into the Sendai virus genome: Sizes of inserted genes and viral replication
38. Recombinant measles viruses efficiently entering cells through targeted receptors
39. Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes
40. Gene therapy: Promises, problems, and prospects
41. Ganciclovir-induced ablation of non-proliferating thyrocytes expressing herpes thymidine kinase occurs by p53-independent apoptosis
42. Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells